Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase III, double-blind, randomized, multicenter primary vaccination study to bridge the DTPa-HBV-IPV vaccine manufactured according to the large scale manufacturing process with the DTPa-HBV-IPV vaccine manufactured by the small scale manufacturing process when administered intramuscularly to infants at 2, 4 and 6 months of age, co-administered with Merck's Hib conjugate vaccine (Liquid PedvaxHIB®) in a separate injection at 2 and 4 months of age https://kusajili.com:443/Trial/DUMuszdA70uIbsaMs-bHBw%24a-phase-iii-double-blind-randomized-multicenter-primary-vaccination-study-to-bridge-the-dtpa-hbv-ipv-vaccine-manufactured-accor
I have read and accept the terms of use of the site and the Privacy Policy
Send your message